Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
Journal of Visualized Experiments · 2025
DOI: 10.3791/68104 ↗Kurz gefasst
Video/Audio in der Zeitschrift Journal of Visualized Experiments, 2025. Verfasst von Deborah da Costa Rodrigues und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Neuroquímica, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro. Hauptthemen laut MEDLINE: Cannabis, Cannabidiol, Plant Extracts, Mouth Mucosa. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben.
Abstract (Originalsprache)
Oral administration of drugs in laboratory rodents such as rats is conventionally performed using the gavage technique. Despite effectiveness, gavage can induce distress associated with restraint, especially following repeated animal handling. To mitigate these adverse effects and reduce morbidity associated with traditional methods, we explored oromucosal/buccal administration of cannabidiol (CBD)-enriched Cannabis extract. In this method, male rats were treated daily for 15 days with medium-chain triglycerides (TCM) derived from coconut oil or CBD-enriched Cannabis extract. Each treatment was administered individually while animals were gently immobilized using an affectionate touch technique. The administration involved the use of a micropipette to apply the oily formulation directly into the oral mucosa. The dosage was calculated based on the CBD concentration in the Cannabis extract, standardized at 3 mg/kg/day. To ensure accuracy, animals were weighed daily, allowing for dose adjustments in accordance with weight changes over the treatment period. This method offers non-invasive and stress-reducing treatment, potentially improving animal welfare in experimental settings. The treatment with CBD-enriched Cannabis extract was safe, and the analysis of the hippocampus of these animals' showed alterations in the expression levels of GluA1 and GFAP proteins, which are directly associated with glutamatergic receptor functionality and neuroinflammation, respectively. This suggests that Cannabis extract could be applied in pathological conditions where glutamatergic excitotoxicity and astrogliosis are observed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratório de Neuroquímica, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro.
- Laboratório de Neuroquímica, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro; Laboratório Intermediário de Neuropatologia Experimental, Instituto de Biofísica Carlos Chagas Filho, Univ…
- Laboratório de Neuroquímica, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro; sampaio.lu@biof.ufrj.br.
Zitieren
APA
da Costa Rodrigues, D., Lourenço de Aguiar, A. F., Paes Colli, Y., Pereira Campos, R. M., de Melo Reis, R. A., & Sampaio, L. S. (2025). Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents. Journal of Visualized Experiments. https://doi.org/10.3791/68104
Vancouver
da Costa Rodrigues D, Lourenço de Aguiar AF, Paes Colli Y, Pereira Campos RM, de Melo Reis RA, Sampaio LS. Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents. Journal of Visualized Experiments. 2025. doi:10.3791/68104
BibTeX
@article{daCostaRodrigues2025,
author = {da Costa Rodrigues, Deborah and Lourenço de Aguiar, Andrey Fabiano and Paes Colli, Yolanda and Pereira Campos, Raquel Maria and de Melo Reis, Ricardo Augusto and Sampaio, Luzia Silva},
title = {Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents},
journal = {Journal of Visualized Experiments},
year = {2025},
doi = {10.3791/68104}
}
EUVIMED